| 000 | 00931 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250513033213.0 | ||
| 264 | 0 | _c19951201 | |
| 008 | 199512s 0 0 eng d | ||
| 022 | _a0090-3493 | ||
| 024 | 7 |
_a10.1097/00003246-199510000-00032 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHamilton-Davies, C | |
| 245 | 0 | 0 |
_aMonophosphoryl lipid A and endotoxin tolerance. _h[electronic resource] |
| 260 |
_bCritical care medicine _cOct 1995 |
||
| 300 |
_a1789-90 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xtherapeutic use |
| 650 | 0 | 4 |
_aEndotoxins _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmune Tolerance _xdrug effects |
| 650 | 0 | 4 |
_aLipid A _xanalogs & derivatives |
| 700 | 1 | _aWebb, A R | |
| 773 | 0 |
_tCritical care medicine _gvol. 23 _gno. 10 _gp. 1789-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00003246-199510000-00032 _zAvailable from publisher's website |
| 999 |
_c7586690 _d7586690 |
||